A. Alexandrou

Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia

Alex Gutteridge, S. Waxman, Lishuang Cao, 2016, Science Translational Medicine.

Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin

Jules C Hancox, Derek J Leishman, Harry J Witchel, 2006, British journal of pharmacology.

A novel selective and orally bioavailable Nav1.8 channel blocker, PF‐01247324, attenuates nociception and sensory neuron excitability

Peter J Bungay, Praveen Anand, P. Anand, 2015, British journal of pharmacology.

Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release

Sulayman D. Dib-Hajj, Stephen G. Waxman, R. Ian Storer, 2016, PloS one.

An Intracellular Allosteric Modulator Binding Pocket in SK2 Ion Channels Is Shared by Multiple Chemotypes.

Jerry R. Hobbs, J. Pandit, R. Horst, 2018, Structure.

The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.

B. Fermini, J. Hancox, A. Alexandrou, 2014, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes.

Brian E Marron, Neil A Castle, Rubben Torella, 2017, Bioorganic & medicinal chemistry letters.

Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia

Alex Gutteridge, S. Waxman, Lishuang Cao, 2016, Science Translational Medicine.